Floatz logo

ip-001

Rectal Cancer With Liver Metastases

Immunophotonics, Inc.Phase 2/3Active
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
95/ 100

Competitive context

69 Active assets in the Rectal Cancer With Liver Metastases cohort.

Asset / SponsorPhaseRating
Irinotecan
Sun Yat-sen University
Phase 4BBB
FLUOROURACILUM
Seoul National University Hospital
Phase 3BBB
Eloxatin
Sun Yat-sen University
Phase 3BBB
Irinotecan
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 3BB
Capecitabine
Tao Zhang
Phase 3BB

View all 50 →

Same molecule, other indications

ip-001 is also rated in:

metastasis from malignant tumor of colonDormant
BB
Indicative ·
64 / 100
View asset →
Colon Cancer Liver MetastasesDormant
B
Indicative ·
57 / 100
View asset →
colorectal cancerDormant
CCC
Indicative ·
52 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →